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Introduction
Dementia is a progressive disease in
which deterioration of the cerebrum
causes a disruption in intellect and
behavior (McCance & Huether, 2019, p.
520). The incidence of dementia increases
with age (Larson, 2019, p. 1). According
to the World Health Organization (WHO),
it affects about “50 million people”
worldwide with close to “10 million new
cases each year” (WHO, 2019). The
diagnosis of dementia is very common in
hospital and outpatient settings. The most
common cause is Alzheimer disease (AD)
consisting of “60% to 80%” of all cases
(Larson, 2019, p. 3).
It is a debilitating disease and has
detrimental effects on the patients,
caregivers, and family. As an emergency
department nurse and a grand-daughter
of a patient struggling with dementia, this
has become a topic of interest.

Signs &
Symptoms
Clinical presentation is a gradual onset
and involves impairment in cognition,
language, and functional ability.
•
•
•
•
•
•
•

Forgetfulness: chief complaint
Difficulty retaining new information
Unable to complete complex tasks
Trouble with reasoning
Disorientation, poor spatial ability
Language impairment
Behavioral disturbances (Larson,
2019, p. 4-5)

Figure 1. Retrieved from
http://images.medicinenet.com/images/slidesho
w/alzheimers-s6-alzheimer-brain-scans.jpg

Underlying Pathophysiology
• Causes of dementia are: infection
(encephalitis, meningitis,
neurosyphilis), normal pressure
hydrocephalus, chronic subdural
hematoma, nutritional deficiencies,
chronic drug or alcohol use, metabolic
disorders (thyroid abnormalities,
hepatic encephalopathy, cerebral
vasculitis, sarcoidosis), tumors,
medication effects (anticholinergics,
antihypertensives, antihistamines),
neurodegenerative disorders
(Alzheimer disease, dementia with
Lewy bodies, Frontotemporal
dementia, Pick disease, Huntington
disease, Parkinson disease), vascular
disease (vascular dementia, multiinfarct, strategic single infarct,
Binswanger disease, Amyloid
angiopathy), irreversible infections
(Creutzfeldt-Jacob disease,
Postencephalitic dementia, HIV)
(McCance & Huether, 2019, p. 521).
• Research is still underway to find a
cause for Alzheimer disease, three
genes on chromosome 21 have been
found to play a role in early onset
familial AD and chromosome 19 has
been linked in late onset AD (McCance
& Huether, 2019, p. 521). The gene
mutations interrupt the brain’s ability
to get rid of beta-amyloid proteins,
which then leads to neurofibrillary
plaque and tangle development that
kills neurons.
• Both the innate and adaptive
inflammatory processes have been
found to have implications in AD
progression. Microglia and astrocytes
are normally protective and regulatory
cells of the brain, however, when betaamyloid and tau protein accumulate,
cytokines (i.e. tumor necrosis factor)
are released and neurons are
destroyed (Eldik, et al, 2016, p. 100102).
• The blood brain barrier (BBB) plays a
part in allowing the influx of
leukocytes when it is damaged by tau
and beta-amyloid proteins. BBB
disruption near the hippocampus,
which is somewhat normal with aging,
occurs at a faster rate with AD, and the
damage to the area around the
hippocampus translates to memory
and language deficits (Zenaro,
Piacentino, & Constatin, 2017, p. 42).

• Inflammatory markers of major
histocompatibility complex (MHC)
class II, cyclooxygenase (COX-2),
monocyte
chemoattractant/chemotactic protein
(MCP-1), tumor necrosis factor alpha
(TNF-a), interleukin beta (IL-b), or IL16 can be found near senile plaques
that are surrounded by microglia and
astrocytes (Hohsfield & Humpel,
2015, p. 10).
• The “neuropathological hallmarks of
AD are neuronal degeneration, loss of
synapses, neurofibrillary tangles,
gliosis, and amyloid-beta
accumulation in senile plaques”
(Zenaro, Piacentino & Constatin,
2017, p. 42). There is also a loss of
acetylcholine related to damage to
cholinergic neurons (McCance &
Huether, 2019, p. 521).
• Arteriosclerosis and atherosclerosis
can lead to infarcts in the brain. A
correlation between beta-amyloid
deposits and decrease in blood flow
has been discovered and has been
theorized to cause cognitive
dysfunction as well as possibly
worsen AD. Because diabetes
mellitus type II and insulin resistance
are linked to vascular disease, they
are risk factors for dementia as well.
The immune system is attributed to
inflammation around plaques and
tangles and impairment of the blood
brain barrier that lead to neurological
damage linked to dementia. The
blood brain barrier may also be
disrupted by alterations in lipid
transport; APOE is involved lipid
transport and if APOE4 is present,
that can indicate a genetic precursor
for AD. Another factor is lack of
collateral circulation in the cerebral
pia during a cerebral vascular
accident that limits the access of back
up blood flow (Snyder et al, 2015 p. 24).

Significance of Pathophysiology
Reversible forms of dementia should be ruled out and treated before a diagnosis of Alzheimer’s disease is confirmed. More research is
needed to determine how to slow down the inflammatory process and stop the deposits of beta-amyloid and tau proteins from forming.
Lifestyle modifications to reduce the risk of vascular disease are important. Prevention and proper management of arteriosclerosis,
atherosclerosis, and diabetes could reduce the risk for developing dementia.
Age is considered the greatest contributing factor to dementia, but despite that, misconceptions exist that cognitive deficits are a
normal part of aging (Stewart et al., 2014, p. 276). Diagnosis is commonly made when a person is already moderately to severely affected
by the disease, but early cognitive testing is an important aspect in diagnosis of dementia and might be beneficial if conducted prior to
onset of obvious signs of impairment. Symptom management is crucial to try to preserve the patient’s quality of life, especially because no
curative treatment is available.

Nursing
Implications
•

•
•

•

•

•

•

Nursing must consider the
nonpharmacological approaches for
dementia care, such as exercise and
cognitive therapy.
Patient safety should be constantly
assessed, and the environment
modified as needed.
Education is very important for all the
primary caregivers. Dementia
disease process and treatment
options should be discussed with the
patient and family.
Encouragement of proper nutrition,
sleep, elimination and management of
chronic diseases, such as
hypertension, diabetes, heart disease,
etc. with medication compliance is an
important part of care and may slow
disease progression.
Watching for side effects of treatment
as well as changes in behavior and
worsening cognitive function are
essential parts of the assessment.
The patient should be encouraged to
perform or participate in all activities
of daily living with a goal of
maintaining independence for as long
as possible.
Advance directives and goals of care
should be discussed with the patient
and family.

Conclusion
Figure 2. Retrieved from
https://mappingignorance.org/fx/media/2014/10/I
mage1.jpg

Figure 3. World Health Organization, 2019.

Case Study
A 70-year-old female presents to her primary care provider with complaints of disorientation (especially at night), forgetfulness, and
difficulty completing activities of daily living. The diagnosis of dementia is established after a thorough history and physical are completed
as well as the Mini-Mental Status Exam, and other potential causes are ruled out with diagnostic blood work and imaging of the brain.
Other signs and symptoms might include “a serious loss of at least 2 cognitive functions, such as memory, attention, thinking, or language”
(Stewart, et al, 2014, p. 275).
The patient is started on memantine to help slow down the progression of dementia. In a systematic review by Buckley and Salpeter
(2015) found that cholinesterase inhibitors have minimal benefit and are cautioned related to the side effects and memantine proved also
to have minimal benefit but less side effects (p. 462). An anti-depressant medication is also added to manage neuropsychiatric symptoms.
Serotonin reuptake inhibitors, especially citalopram, have been helpful for agitation and paranoia (Press & Alexander, 2018). The primary
health care provider enlists multi-disciplinary approach including nursing, pharmacy, physical/occupational therapy, dietary, and case
management.

Alzheimer disease is a progressive
disease causing cognitive and functional
decline with the hallmark sign of
plagues and tangles within the brain.
Genetics, inflammation, accumulation of
beta-amyloid protein and breakdown of
the blood brain barrier are all
contributing factors in the disease.
Treatment is not curative and is focused
on symptom management and
management of pre-existing chronic
diseases.
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